Rank | Gene Set | Z-score |
---|---|---|
1 | sulfur amino acid catabolic process (GO:0000098) | 5.21963428 |
2 | cellular modified amino acid catabolic process (GO:0042219) | 4.91631286 |
3 | hemidesmosome assembly (GO:0031581) | 4.82923190 |
4 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.74671371 |
5 | urea cycle (GO:0000050) | 4.70901355 |
6 | urea metabolic process (GO:0019627) | 4.70901355 |
7 | L-phenylalanine catabolic process (GO:0006559) | 4.61310619 |
8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.61310619 |
9 | L-phenylalanine metabolic process (GO:0006558) | 4.60982282 |
10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.60982282 |
11 | coenzyme catabolic process (GO:0009109) | 4.50951567 |
12 | kynurenine metabolic process (GO:0070189) | 4.45367102 |
13 | aromatic amino acid family catabolic process (GO:0009074) | 4.40230251 |
14 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37362997 |
15 | negative regulation of fibrinolysis (GO:0051918) | 4.26917410 |
16 | indole-containing compound catabolic process (GO:0042436) | 4.21892086 |
17 | indolalkylamine catabolic process (GO:0046218) | 4.21892086 |
18 | tryptophan catabolic process (GO:0006569) | 4.21892086 |
19 | nitrogen cycle metabolic process (GO:0071941) | 4.18612126 |
20 | cysteine metabolic process (GO:0006534) | 4.14724247 |
21 | polyketide metabolic process (GO:0030638) | 4.10165411 |
22 | doxorubicin metabolic process (GO:0044598) | 4.10165411 |
23 | daunorubicin metabolic process (GO:0044597) | 4.10165411 |
24 | hormone catabolic process (GO:0042447) | 4.09133250 |
25 | epoxygenase P450 pathway (GO:0019373) | 4.06247509 |
26 | complement activation, alternative pathway (GO:0006957) | 4.03103660 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.00506585 |
28 | tryptophan metabolic process (GO:0006568) | 3.94773334 |
29 | regulation of protein activation cascade (GO:2000257) | 3.92040607 |
30 | negative regulation of sterol transport (GO:0032372) | 3.91443414 |
31 | negative regulation of cholesterol transport (GO:0032375) | 3.91443414 |
32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.89436731 |
33 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.86468891 |
34 | protein carboxylation (GO:0018214) | 3.83724595 |
35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.83724595 |
36 | serine family amino acid catabolic process (GO:0009071) | 3.81820586 |
37 | semaphorin-plexin signaling pathway (GO:0071526) | 3.76598548 |
38 | glyoxylate metabolic process (GO:0046487) | 3.73629167 |
39 | regulation of fibrinolysis (GO:0051917) | 3.72629262 |
40 | Golgi transport vesicle coating (GO:0048200) | 3.70288413 |
41 | COPI coating of Golgi vesicle (GO:0048205) | 3.70288413 |
42 | regulation of complement activation (GO:0030449) | 3.69535401 |
43 | bile acid biosynthetic process (GO:0006699) | 3.68684542 |
44 | reverse cholesterol transport (GO:0043691) | 3.67509465 |
45 | complement activation, classical pathway (GO:0006958) | 3.66393657 |
46 | phospholipid efflux (GO:0033700) | 3.62389972 |
47 | regulation of cholesterol homeostasis (GO:2000188) | 3.58839668 |
48 | cell-substrate junction assembly (GO:0007044) | 3.58505633 |
49 | protein retention in ER lumen (GO:0006621) | 3.55403851 |
50 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.54601304 |
51 | desmosome organization (GO:0002934) | 3.53564743 |
52 | regulation of triglyceride catabolic process (GO:0010896) | 3.51843183 |
53 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.50474539 |
54 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.50456496 |
55 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.49736371 |
56 | plasma lipoprotein particle clearance (GO:0034381) | 3.46887083 |
57 | adherens junction assembly (GO:0034333) | 3.43928764 |
58 | phospholipid homeostasis (GO:0055091) | 3.43792338 |
59 | homocysteine metabolic process (GO:0050667) | 3.42962563 |
60 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.42935871 |
61 | complement activation (GO:0006956) | 3.38194129 |
62 | regulation of cholesterol esterification (GO:0010872) | 3.37253565 |
63 | cell-substrate adherens junction assembly (GO:0007045) | 3.37220752 |
64 | focal adhesion assembly (GO:0048041) | 3.37220752 |
65 | lysine metabolic process (GO:0006553) | 3.36550317 |
66 | lysine catabolic process (GO:0006554) | 3.36550317 |
67 | primary alcohol catabolic process (GO:0034310) | 3.35916891 |
68 | cell-cell junction maintenance (GO:0045217) | 3.34967395 |
69 | glycine metabolic process (GO:0006544) | 3.34952402 |
70 | positive regulation of histone deacetylation (GO:0031065) | 3.33806498 |
71 | activation of Rac GTPase activity (GO:0032863) | 3.32315325 |
72 | protein-lipid complex remodeling (GO:0034368) | 3.29775606 |
73 | macromolecular complex remodeling (GO:0034367) | 3.29775606 |
74 | plasma lipoprotein particle remodeling (GO:0034369) | 3.29775606 |
75 | bile acid metabolic process (GO:0008206) | 3.27479547 |
76 | negative regulation of fatty acid transport (GO:2000192) | 3.25896527 |
77 | protein localization to endosome (GO:0036010) | 3.21318091 |
78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.19286885 |
79 | acylglycerol homeostasis (GO:0055090) | 3.19201942 |
80 | triglyceride homeostasis (GO:0070328) | 3.19201942 |
81 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.18535601 |
82 | drug metabolic process (GO:0017144) | 3.16474146 |
83 | epithelial cell-cell adhesion (GO:0090136) | 3.15508882 |
84 | skin morphogenesis (GO:0043589) | 3.14745708 |
85 | heme transport (GO:0015886) | 3.14669903 |
86 | cofactor catabolic process (GO:0051187) | 3.13552801 |
87 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.13346919 |
88 | valine metabolic process (GO:0006573) | 3.13232711 |
89 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.12717121 |
90 | bile acid and bile salt transport (GO:0015721) | 3.12486690 |
91 | basement membrane organization (GO:0071711) | 3.12132827 |
92 | cholesterol efflux (GO:0033344) | 3.11549943 |
93 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.11521912 |
94 | alpha-amino acid catabolic process (GO:1901606) | 3.11133957 |
95 | ethanol oxidation (GO:0006069) | 3.10469911 |
96 | positive regulation of lipid catabolic process (GO:0050996) | 3.10462579 |
97 | glucose 6-phosphate metabolic process (GO:0051156) | 3.10414367 |
98 | plasma lipoprotein particle assembly (GO:0034377) | 3.08926752 |
99 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.08427290 |
100 | cellular amino acid catabolic process (GO:0009063) | 3.07734415 |
101 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.06900803 |
102 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.05668262 |
103 | aromatic amino acid family metabolic process (GO:0009072) | 3.05510969 |
104 | protein-lipid complex assembly (GO:0065005) | 3.02876815 |
105 | apoptotic process involved in morphogenesis (GO:0060561) | 3.01918302 |
106 | cell adhesion mediated by integrin (GO:0033627) | 2.99835367 |
107 | amino-acid betaine metabolic process (GO:0006577) | 2.99651029 |
108 | maternal placenta development (GO:0001893) | 2.98277252 |
109 | protein activation cascade (GO:0072376) | 2.97779904 |
110 | serine family amino acid metabolic process (GO:0009069) | 2.97621971 |
111 | lipoprotein metabolic process (GO:0042157) | 2.95527714 |
112 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.94877217 |
113 | ear development (GO:0043583) | 2.94418325 |
114 | heterochromatin organization (GO:0070828) | 2.92730404 |
115 | regulation of lipoprotein particle clearance (GO:0010984) | 2.91524585 |
116 | drug catabolic process (GO:0042737) | 2.89356060 |
117 | activation of MAPKKK activity (GO:0000185) | 2.85538654 |
118 | cholesterol homeostasis (GO:0042632) | 2.82521623 |
119 | low-density lipoprotein particle clearance (GO:0034383) | 2.82445561 |
120 | biotin metabolic process (GO:0006768) | 2.81137585 |
121 | tyrosine metabolic process (GO:0006570) | 2.80726940 |
122 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.80528837 |
123 | flavonoid metabolic process (GO:0009812) | 2.79597744 |
124 | sterol homeostasis (GO:0055092) | 2.78907835 |
125 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.78620883 |
126 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.78620883 |
127 | benzene-containing compound metabolic process (GO:0042537) | 2.77337939 |
128 | regulation of early endosome to late endosome transport (GO:2000641) | 2.77220002 |
129 | regulation of cholesterol storage (GO:0010885) | 2.75290800 |
130 | glutamate metabolic process (GO:0006536) | 2.74902445 |
131 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.74279592 |
132 | indolalkylamine metabolic process (GO:0006586) | 2.74209209 |
133 | apoptotic cell clearance (GO:0043277) | 2.73966373 |
134 | surfactant homeostasis (GO:0043129) | 2.73851337 |
135 | L-ascorbic acid metabolic process (GO:0019852) | 2.72748956 |
136 | positive regulation of protein deacetylation (GO:0090312) | 2.71492432 |
137 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.70794801 |
138 | imidazole-containing compound metabolic process (GO:0052803) | 2.70466405 |
139 | paraxial mesoderm development (GO:0048339) | 2.69878402 |
140 | proline biosynthetic process (GO:0006561) | 2.67631808 |
141 | proline metabolic process (GO:0006560) | 2.61103950 |
142 | establishment of apical/basal cell polarity (GO:0035089) | 2.59419275 |
143 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.59378475 |
144 | regulation of bile acid biosynthetic process (GO:0070857) | 2.57591969 |
145 | endothelial cell chemotaxis (GO:0035767) | 2.57121065 |
146 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56984695 |
147 | cell junction maintenance (GO:0034331) | 2.56643456 |
148 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.55277154 |
149 | cellular response to prostaglandin stimulus (GO:0071379) | 2.55003859 |
150 | regulation of plasminogen activation (GO:0010755) | 2.54095163 |
151 | cellular response to virus (GO:0098586) | 2.50987664 |
152 | receptor catabolic process (GO:0032801) | 2.50684193 |
153 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.50209936 |
154 | modulation by symbiont of host cellular process (GO:0044068) | 2.50152583 |
155 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.49997149 |
156 | gap junction assembly (GO:0016264) | 2.48382279 |
157 | negative regulation of lipid transport (GO:0032369) | 2.47947690 |
158 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.47208387 |
159 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.45083628 |
160 | embryonic process involved in female pregnancy (GO:0060136) | 2.44554239 |
161 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.43084521 |
162 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.43084521 |
163 | regulation of extracellular matrix organization (GO:1903053) | 2.40988197 |
164 | modulation by virus of host morphology or physiology (GO:0019048) | 2.40721019 |
165 | layer formation in cerebral cortex (GO:0021819) | 2.39997769 |
166 | intestinal cholesterol absorption (GO:0030299) | 2.39812271 |
167 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.38219990 |
168 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.38090790 |
169 | skeletal muscle organ development (GO:0060538) | 2.37474463 |
170 | regulation of apoptotic cell clearance (GO:2000425) | 2.36575453 |
171 | diaphragm development (GO:0060539) | 2.36486354 |
172 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.36014311 |
173 | convergent extension (GO:0060026) | 2.35667083 |
174 | adherens junction organization (GO:0034332) | 2.35652449 |
175 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.33518803 |
176 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.32484153 |
177 | stress fiber assembly (GO:0043149) | 2.32329830 |
178 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.32299985 |
179 | eye morphogenesis (GO:0048592) | 2.31929042 |
180 | cell migration in hindbrain (GO:0021535) | 2.31819344 |
181 | actin filament bundle assembly (GO:0051017) | 2.30823095 |
182 | actin filament bundle organization (GO:0061572) | 2.30823095 |
183 | negative regulation of cell size (GO:0045792) | 2.30773274 |
184 | positive regulation of hormone metabolic process (GO:0032352) | 2.30510812 |
185 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.30388276 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.22568311 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.16422545 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.53976415 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.31160789 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.69120609 |
6 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.27379666 |
7 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.27379666 |
8 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.27379666 |
9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.02394649 |
10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.85233103 |
11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.81745080 |
12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75695959 |
13 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.70356405 |
14 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.65869840 |
15 | MYC_22102868_ChIP-Seq_BL_Human | 2.63746740 |
16 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.57493830 |
17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.36032352 |
18 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.24995691 |
19 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.20180297 |
20 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.06769386 |
21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.05980055 |
22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.01148053 |
23 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.98825154 |
24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.93429119 |
25 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.91153276 |
26 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.88410718 |
27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87757613 |
28 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.83742999 |
29 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.80680748 |
30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.74846363 |
31 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67998104 |
32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.65555211 |
33 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.62957348 |
34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.59059659 |
35 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.56601607 |
36 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.55503483 |
37 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.53901769 |
38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53650511 |
39 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.52751819 |
40 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.52566950 |
41 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.49760405 |
42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49480084 |
43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49143325 |
44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.48449823 |
45 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.46397167 |
46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.45809975 |
47 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.44002797 |
48 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.43805523 |
49 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.42801682 |
50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.42687373 |
51 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.40664752 |
52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39426709 |
53 | * CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.36901541 |
54 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36729520 |
55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36492018 |
56 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.36010530 |
57 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.35686869 |
58 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.35025987 |
59 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.34078769 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.32752656 |
61 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.31935440 |
62 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.30773755 |
63 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.29451135 |
64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29283963 |
65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.28842907 |
66 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.27436174 |
67 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26190643 |
68 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25816867 |
69 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24862513 |
70 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.24050432 |
71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.23820659 |
72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23705741 |
73 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.22780434 |
74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22766712 |
75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21996359 |
76 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.21225994 |
77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.20857078 |
78 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19960035 |
79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19331132 |
80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19014464 |
81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.18274101 |
82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18001704 |
83 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17297758 |
84 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.16552505 |
85 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14985611 |
86 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.14670670 |
87 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.11834222 |
88 | * TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11294433 |
89 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.11142879 |
90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10746263 |
91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10478121 |
92 | MAF_26560356_Chip-Seq_TH1_Human | 1.10406057 |
93 | P68_20966046_ChIP-Seq_HELA_Human | 1.10234838 |
94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.10007548 |
95 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09155921 |
96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.08031273 |
97 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.07613086 |
98 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07324618 |
99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07048307 |
100 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06785711 |
101 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.05992704 |
102 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.05651234 |
103 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05562327 |
104 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05223255 |
105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.04184809 |
106 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03217881 |
107 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.02157453 |
108 | * POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.01509548 |
109 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01253272 |
110 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01203917 |
111 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01110043 |
112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00904192 |
113 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00292352 |
114 | MYB_26560356_Chip-Seq_TH1_Human | 1.00291524 |
115 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.99898103 |
116 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.99853278 |
117 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99808296 |
118 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.99721316 |
119 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99362940 |
120 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99316823 |
121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98494610 |
122 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98466214 |
123 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.96638956 |
124 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.96638956 |
125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95630025 |
126 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.95329469 |
127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.94581350 |
128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93998056 |
129 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.93419076 |
130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91387469 |
131 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90055235 |
132 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89644335 |
133 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.89332038 |
134 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.88095876 |
135 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.85786771 |
136 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85677462 |
137 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84315893 |
138 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84215847 |
139 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.83512482 |
140 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.83371504 |
141 | * CTCF_21964334_Chip-Seq_Bcells_Human | 0.83171803 |
142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82104136 |
143 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.81895347 |
144 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.81087242 |
145 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.80699489 |
146 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.80502476 |
147 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80356390 |
148 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.80175997 |
149 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.79895355 |
150 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79339528 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 5.46154517 |
2 | MP0005360_urolithiasis | 5.37266669 |
3 | MP0005365_abnormal_bile_salt | 4.05321270 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.03816540 |
5 | MP0002254_reproductive_system_inflammat | 3.65667055 |
6 | MP0003705_abnormal_hypodermis_morpholog | 3.49203997 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.26993251 |
8 | MP0003252_abnormal_bile_duct | 3.19584546 |
9 | MP0000566_synostosis | 2.90856696 |
10 | MP0009840_abnormal_foam_cell | 2.89854333 |
11 | MP0005409_darkened_coat_color | 2.77906552 |
12 | MP0010329_abnormal_lipoprotein_level | 2.59054224 |
13 | MP0004264_abnormal_extraembryonic_tissu | 2.49247205 |
14 | MP0000579_abnormal_nail_morphology | 2.48589386 |
15 | MP0003011_delayed_dark_adaptation | 2.48287725 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.45233991 |
17 | MP0002089_abnormal_postnatal_growth/wei | 2.41305589 |
18 | MP0001348_abnormal_lacrimal_gland | 2.32501015 |
19 | MP0000537_abnormal_urethra_morphology | 2.27552776 |
20 | MP0005083_abnormal_biliary_tract | 2.16768535 |
21 | MP0000609_abnormal_liver_physiology | 2.11654135 |
22 | MP0003453_abnormal_keratinocyte_physiol | 2.10637639 |
23 | MP0004272_abnormal_basement_membrane | 2.07510750 |
24 | MP0003941_abnormal_skin_development | 2.05674294 |
25 | MP0003806_abnormal_nucleotide_metabolis | 2.04504388 |
26 | MP0010352_gastrointestinal_tract_polyps | 1.89546306 |
27 | MP0005058_abnormal_lysosome_morphology | 1.83145979 |
28 | MP0003123_paternal_imprinting | 1.78092866 |
29 | MP0002877_abnormal_melanocyte_morpholog | 1.75835545 |
30 | MP0002138_abnormal_hepatobiliary_system | 1.75018854 |
31 | MP0003890_abnormal_embryonic-extraembry | 1.73429635 |
32 | MP0000678_abnormal_parathyroid_gland | 1.65231655 |
33 | MP0005332_abnormal_amino_acid | 1.63773978 |
34 | MP0002796_impaired_skin_barrier | 1.62596742 |
35 | MP0001666_abnormal_nutrient_absorption | 1.62090637 |
36 | * MP0003091_abnormal_cell_migration | 1.59693079 |
37 | MP0008961_abnormal_basal_metabolism | 1.57529743 |
38 | * MP0005319_abnormal_enzyme/_coenzyme | 1.54844497 |
39 | MP0002098_abnormal_vibrissa_morphology | 1.50797393 |
40 | MP0000762_abnormal_tongue_morphology | 1.47679269 |
41 | MP0005623_abnormal_meninges_morphology | 1.46935490 |
42 | MP0004858_abnormal_nervous_system | 1.46582840 |
43 | MP0008260_abnormal_autophagy | 1.46458073 |
44 | MP0006082_CNS_inflammation | 1.44041157 |
45 | MP0008438_abnormal_cutaneous_collagen | 1.41033783 |
46 | MP0005501_abnormal_skin_physiology | 1.40612484 |
47 | MP0000467_abnormal_esophagus_morphology | 1.39388078 |
48 | MP0001835_abnormal_antigen_presentation | 1.37229796 |
49 | MP0003115_abnormal_respiratory_system | 1.35786942 |
50 | MP0002249_abnormal_larynx_morphology | 1.35531810 |
51 | MP0009780_abnormal_chondrocyte_physiolo | 1.34753073 |
52 | MP0003122_maternal_imprinting | 1.34168055 |
53 | MP0002118_abnormal_lipid_homeostasis | 1.33575454 |
54 | MP0003329_amyloid_beta_deposits | 1.31675522 |
55 | MP0004019_abnormal_vitamin_homeostasis | 1.30838467 |
56 | MP0003942_abnormal_urinary_system | 1.30505309 |
57 | MP0002822_catalepsy | 1.28857920 |
58 | MP0000598_abnormal_liver_morphology | 1.28282460 |
59 | MP0003300_gastrointestinal_ulcer | 1.27374577 |
60 | MP0002060_abnormal_skin_morphology | 1.24074700 |
61 | MP0005670_abnormal_white_adipose | 1.21545527 |
62 | MP0000003_abnormal_adipose_tissue | 1.20952466 |
63 | MP0000534_abnormal_ureter_morphology | 1.19904184 |
64 | MP0001216_abnormal_epidermal_layer | 1.19828321 |
65 | * MP0001800_abnormal_humoral_immune | 1.18794750 |
66 | MP0004233_abnormal_muscle_weight | 1.17006433 |
67 | MP0003436_decreased_susceptibility_to | 1.16987237 |
68 | MP0002896_abnormal_bone_mineralization | 1.15419296 |
69 | * MP0002697_abnormal_eye_size | 1.15210729 |
70 | MP0002332_abnormal_exercise_endurance | 1.14643112 |
71 | MP0005387_immune_system_phenotype | 1.12609334 |
72 | MP0001790_abnormal_immune_system | 1.12609334 |
73 | MP0003303_peritoneal_inflammation | 1.08868271 |
74 | MP0000685_abnormal_immune_system | 1.07334983 |
75 | MP0001849_ear_inflammation | 1.05860738 |
76 | MP0005076_abnormal_cell_differentiation | 1.05365491 |
77 | MP0002088_abnormal_embryonic_growth/wei | 1.05043179 |
78 | MP0010030_abnormal_orbit_morphology | 1.04605880 |
79 | MP0003315_abnormal_perineum_morphology | 1.02765492 |
80 | MP0005075_abnormal_melanosome_morpholog | 1.01711040 |
81 | MP0000462_abnormal_digestive_system | 1.01491731 |
82 | MP0003984_embryonic_growth_retardation | 1.00867403 |
83 | MP0003868_abnormal_feces_composition | 1.00126420 |
84 | MP0001672_abnormal_embryogenesis/_devel | 0.99110282 |
85 | MP0005380_embryogenesis_phenotype | 0.99110282 |
86 | MP0000858_altered_metastatic_potential | 0.98900640 |
87 | MP0003566_abnormal_cell_adhesion | 0.96688632 |
88 | MP0003385_abnormal_body_wall | 0.95272621 |
89 | MP0005647_abnormal_sex_gland | 0.94831983 |
90 | MP0000377_abnormal_hair_follicle | 0.94232473 |
91 | MP0000733_abnormal_muscle_development | 0.94016983 |
92 | MP0005375_adipose_tissue_phenotype | 0.93944608 |
93 | MP0006035_abnormal_mitochondrial_morpho | 0.93272195 |
94 | MP0005023_abnormal_wound_healing | 0.93169048 |
95 | MP0002970_abnormal_white_adipose | 0.93009183 |
96 | * MP0009643_abnormal_urine_homeostasis | 0.92513868 |
97 | MP0009115_abnormal_fat_cell | 0.90793978 |
98 | MP0010678_abnormal_skin_adnexa | 0.89661555 |
99 | * MP0005584_abnormal_enzyme/coenzyme_acti | 0.86206369 |
100 | MP0002086_abnormal_extraembryonic_tissu | 0.85372412 |
101 | MP0009384_cardiac_valve_regurgitation | 0.85127209 |
102 | MP0005666_abnormal_adipose_tissue | 0.84764738 |
103 | MP0010368_abnormal_lymphatic_system | 0.83169753 |
104 | MP0009763_increased_sensitivity_to | 0.82401218 |
105 | * MP0008469_abnormal_protein_level | 0.80702328 |
106 | MP0004185_abnormal_adipocyte_glucose | 0.80318205 |
107 | MP0000477_abnormal_intestine_morphology | 0.79006231 |
108 | MP0003172_abnormal_lysosome_physiology | 0.78929695 |
109 | MP0002928_abnormal_bile_duct | 0.78724615 |
110 | MP0005266_abnormal_metabolism | 0.78326491 |
111 | MP0002116_abnormal_craniofacial_bone | 0.78323072 |
112 | * MP0002452_abnormal_antigen_presenting | 0.77909163 |
113 | MP0002396_abnormal_hematopoietic_system | 0.77219415 |
114 | MP0000432_abnormal_head_morphology | 0.76814703 |
115 | * MP0000689_abnormal_spleen_morphology | 0.76313754 |
116 | MP0002085_abnormal_embryonic_tissue | 0.76152902 |
117 | MP0010234_abnormal_vibrissa_follicle | 0.75918299 |
118 | MP0009764_decreased_sensitivity_to | 0.75369630 |
119 | * MP0002136_abnormal_kidney_physiology | 0.74615127 |
120 | MP0003634_abnormal_glial_cell | 0.73115520 |
121 | * MP0002092_abnormal_eye_morphology | 0.73070020 |
122 | MP0000604_amyloidosis | 0.72495401 |
123 | * MP0003861_abnormal_nervous_system | 0.72341022 |
124 | MP0000428_abnormal_craniofacial_morphol | 0.72320890 |
125 | MP0001299_abnormal_eye_distance/ | 0.71448065 |
126 | MP0003935_abnormal_craniofacial_develop | 0.71383479 |
127 | MP0009931_abnormal_skin_appearance | 0.71142423 |
128 | MP0004197_abnormal_fetal_growth/weight/ | 0.69497756 |
129 | MP0003755_abnormal_palate_morphology | 0.69444365 |
130 | * MP0005621_abnormal_cell_physiology | 0.69376879 |
131 | MP0005248_abnormal_Harderian_gland | 0.69050605 |
132 | MP0004270_analgesia | 0.68759989 |
133 | MP0000627_abnormal_mammary_gland | 0.68479091 |
134 | MP0002111_abnormal_tail_morphology | 0.68376332 |
135 | MP0000569_abnormal_digit_pigmentation | 0.66185617 |
136 | MP0004947_skin_inflammation | 0.65743588 |
137 | MP0001845_abnormal_inflammatory_respons | 0.65381223 |
138 | MP0009053_abnormal_anal_canal | 0.64861625 |
139 | MP0009765_abnormal_xenobiotic_induced | 0.64325886 |
140 | MP0000350_abnormal_cell_proliferation | 0.62367856 |
141 | MP0002722_abnormal_immune_system | 0.62302870 |
142 | MP0005499_abnormal_olfactory_system | 0.61562871 |
143 | MP0005394_taste/olfaction_phenotype | 0.61562871 |
144 | MP0009672_abnormal_birth_weight | 0.60594717 |
145 | MP0005464_abnormal_platelet_physiology | 0.59442258 |
146 | * MP0002723_abnormal_immune_serum | 0.58306470 |
147 | * MP0000716_abnormal_immune_system | 0.57811656 |
148 | MP0005000_abnormal_immune_tolerance | 0.57756780 |
149 | MP0003656_abnormal_erythrocyte_physiolo | 0.57115369 |
150 | MP0004782_abnormal_surfactant_physiolog | 0.56810590 |
151 | * MP0009642_abnormal_blood_homeostasis | 0.56757904 |
152 | MP0005451_abnormal_body_composition | 0.56225917 |
153 | MP0002653_abnormal_ependyma_morphology | 0.55919876 |
154 | MP0001730_embryonic_growth_arrest | 0.55896555 |
155 | MP0001915_intracranial_hemorrhage | 0.55469715 |
156 | * MP0002429_abnormal_blood_cell | 0.55362581 |
157 | MP0004883_abnormal_blood_vessel | 0.55175889 |
158 | MP0008057_abnormal_DNA_replication | 0.54980291 |
159 | MP0005334_abnormal_fat_pad | 0.54592692 |
160 | MP0005376_homeostasis/metabolism_phenot | 0.53932330 |
161 | MP0004957_abnormal_blastocyst_morpholog | 0.53459440 |
162 | MP0009278_abnormal_bone_marrow | 0.53328676 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypochromic microcytic anemia (HP:0004840) | 5.21868352 |
2 | Deep venous thrombosis (HP:0002625) | 4.92206533 |
3 | Complement deficiency (HP:0004431) | 4.30956728 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.28956484 |
5 | Intrahepatic cholestasis (HP:0001406) | 4.19743644 |
6 | Xanthomatosis (HP:0000991) | 4.15721253 |
7 | Abnormality of the lower motor neuron (HP:0002366) | 4.03162532 |
8 | Hyperacusis (HP:0010780) | 3.87664231 |
9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.84654717 |
10 | Hepatoblastoma (HP:0002884) | 3.76605184 |
11 | Hypobetalipoproteinemia (HP:0003563) | 3.67974158 |
12 | Multiple enchondromatosis (HP:0005701) | 3.58620185 |
13 | Bilateral microphthalmos (HP:0007633) | 3.47429159 |
14 | Abnormality of complement system (HP:0005339) | 3.46504971 |
15 | Atrophic scars (HP:0001075) | 3.36670468 |
16 | Asymmetry of the thorax (HP:0001555) | 3.33878051 |
17 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23546124 |
18 | Flat acetabular roof (HP:0003180) | 3.20469276 |
19 | Upper motor neuron abnormality (HP:0002127) | 3.18499813 |
20 | Joint hemorrhage (HP:0005261) | 3.06928846 |
21 | Abnormal cartilage morphology (HP:0002763) | 3.06097576 |
22 | Prolonged partial thromboplastin time (HP:0003645) | 3.05103000 |
23 | Myocardial infarction (HP:0001658) | 3.04506801 |
24 | Hypolipoproteinemia (HP:0010981) | 3.01494559 |
25 | Malnutrition (HP:0004395) | 2.99640195 |
26 | Systemic lupus erythematosus (HP:0002725) | 2.98604208 |
27 | Epidermoid cyst (HP:0200040) | 2.94142515 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 2.91520049 |
29 | Protrusio acetabuli (HP:0003179) | 2.89572201 |
30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.87557717 |
31 | Skin nodule (HP:0200036) | 2.86725156 |
32 | Hyperammonemia (HP:0001987) | 2.82395576 |
33 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.81718973 |
34 | Hyperglycinuria (HP:0003108) | 2.80066394 |
35 | Hypercholesterolemia (HP:0003124) | 2.80001744 |
36 | Broad face (HP:0000283) | 2.79573312 |
37 | Hyperlipoproteinemia (HP:0010980) | 2.74670130 |
38 | Colitis (HP:0002583) | 2.68894209 |
39 | Pseudobulbar signs (HP:0002200) | 2.67168201 |
40 | Hypochromic anemia (HP:0001931) | 2.66891933 |
41 | Thin bony cortex (HP:0002753) | 2.62805419 |
42 | Hand muscle atrophy (HP:0009130) | 2.62051633 |
43 | Premature rupture of membranes (HP:0001788) | 2.62034493 |
44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.59201369 |
45 | Glomerulonephritis (HP:0000099) | 2.58791816 |
46 | Abnormality of the Achilles tendon (HP:0005109) | 2.54640881 |
47 | Bronchomalacia (HP:0002780) | 2.51674405 |
48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.48914355 |
49 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.45104065 |
50 | Abnormality of glycine metabolism (HP:0010895) | 2.42180128 |
51 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.42180128 |
52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.40383729 |
53 | Advanced eruption of teeth (HP:0006288) | 2.40292944 |
54 | Ketosis (HP:0001946) | 2.37669001 |
55 | Natal tooth (HP:0000695) | 2.37410903 |
56 | Milia (HP:0001056) | 2.36930433 |
57 | Insomnia (HP:0100785) | 2.33623571 |
58 | Renovascular hypertension (HP:0100817) | 2.33590620 |
59 | Renal duplication (HP:0000075) | 2.30704976 |
60 | Back pain (HP:0003418) | 2.29555356 |
61 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.29111016 |
62 | Fragile skin (HP:0001030) | 2.28423456 |
63 | Shallow orbits (HP:0000586) | 2.23511678 |
64 | Gout (HP:0001997) | 2.23373413 |
65 | Neonatal short-limb short stature (HP:0008921) | 2.21557297 |
66 | Ragged-red muscle fibers (HP:0003200) | 2.19989572 |
67 | Ependymoma (HP:0002888) | 2.19623473 |
68 | Nasal polyposis (HP:0100582) | 2.14941817 |
69 | Abnormality of carpal bone ossification (HP:0006257) | 2.14877544 |
70 | Long palpebral fissure (HP:0000637) | 2.14866643 |
71 | Achilles tendon contracture (HP:0001771) | 2.14430859 |
72 | Elfin facies (HP:0004428) | 2.13708736 |
73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.13541215 |
74 | Spastic diplegia (HP:0001264) | 2.13227724 |
75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13058635 |
76 | Distal upper limb amyotrophy (HP:0007149) | 2.10252168 |
77 | Upper limb amyotrophy (HP:0009129) | 2.10252168 |
78 | Hepatocellular carcinoma (HP:0001402) | 2.10072920 |
79 | Hyperglycinemia (HP:0002154) | 2.08063385 |
80 | Ulnar bowing (HP:0003031) | 2.06729511 |
81 | Overriding aorta (HP:0002623) | 2.06471227 |
82 | Abnormal ossification of hand bones (HP:0005921) | 2.04304161 |
83 | Neoplasm of striated muscle (HP:0009728) | 2.04041223 |
84 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.02820591 |
85 | Esophageal varix (HP:0002040) | 2.00945315 |
86 | Mitral stenosis (HP:0001718) | 2.00404864 |
87 | Abnormality of the gastric mucosa (HP:0004295) | 1.98661619 |
88 | Abnormality of purine metabolism (HP:0004352) | 1.97759790 |
89 | Abnormality of methionine metabolism (HP:0010901) | 1.96760059 |
90 | Amyotrophic lateral sclerosis (HP:0007354) | 1.95853841 |
91 | Vertebral arch anomaly (HP:0008438) | 1.95528332 |
92 | Lymphangioma (HP:0100764) | 1.94806559 |
93 | Pterygium (HP:0001059) | 1.94628274 |
94 | Focal segmental glomerulosclerosis (HP:0000097) | 1.94204459 |
95 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94022054 |
96 | Mitral valve prolapse (HP:0001634) | 1.92980553 |
97 | Bladder diverticulum (HP:0000015) | 1.92267852 |
98 | Fat malabsorption (HP:0002630) | 1.92145016 |
99 | Arnold-Chiari malformation (HP:0002308) | 1.91930975 |
100 | Cervical subluxation (HP:0003308) | 1.91858891 |
101 | Cerebral inclusion bodies (HP:0100314) | 1.90216982 |
102 | Hyperparathyroidism (HP:0000843) | 1.89212977 |
103 | Tetraplegia (HP:0002445) | 1.89115787 |
104 | Testicular atrophy (HP:0000029) | 1.86898247 |
105 | Abnormality of the nasal mucosa (HP:0000433) | 1.86140659 |
106 | Cerebral aneurysm (HP:0004944) | 1.85477614 |
107 | Rib fusion (HP:0000902) | 1.84659025 |
108 | Hemorrhage of the eye (HP:0011885) | 1.84096633 |
109 | Fragile nails (HP:0001808) | 1.83975236 |
110 | Neurofibrillary tangles (HP:0002185) | 1.82929989 |
111 | Nephritis (HP:0000123) | 1.82733705 |
112 | Amyloidosis (HP:0011034) | 1.82019277 |
113 | Peritonitis (HP:0002586) | 1.81877771 |
114 | Progressive sensorineural hearing impairment (HP:0000408) | 1.81291104 |
115 | Turricephaly (HP:0000262) | 1.80899603 |
116 | Abdominal distention (HP:0003270) | 1.80502281 |
117 | Large earlobe (HP:0009748) | 1.79806834 |
118 | Rhabdomyosarcoma (HP:0002859) | 1.76823613 |
119 | Biconcave vertebral bodies (HP:0004586) | 1.76485394 |
120 | Agammaglobulinemia (HP:0004432) | 1.76381957 |
121 | Increased CSF protein (HP:0002922) | 1.75945576 |
122 | Ankyloglossia (HP:0010296) | 1.75509973 |
123 | Gingival bleeding (HP:0000225) | 1.74945149 |
124 | Disproportionate tall stature (HP:0001519) | 1.73531398 |
125 | Right ventricular cardiomyopathy (HP:0011663) | 1.73274580 |
126 | Tibial bowing (HP:0002982) | 1.72883155 |
127 | Germ cell neoplasia (HP:0100728) | 1.72319384 |
128 | Inflammation of the large intestine (HP:0002037) | 1.72085152 |
129 | Abnormality of iron homeostasis (HP:0011031) | 1.71985492 |
130 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.71696814 |
131 | Short nail (HP:0001799) | 1.71601110 |
132 | Cellulitis (HP:0100658) | 1.70391123 |
133 | Cupped ribs (HP:0000887) | 1.70193454 |
134 | Mitral regurgitation (HP:0001653) | 1.69875626 |
135 | Increased connective tissue (HP:0009025) | 1.69805697 |
136 | Gastrointestinal inflammation (HP:0004386) | 1.69238269 |
137 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67277134 |
138 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67277134 |
139 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67277134 |
140 | Arterial tortuosity (HP:0005116) | 1.66407491 |
141 | Camptodactyly of toe (HP:0001836) | 1.66390153 |
142 | Arthropathy (HP:0003040) | 1.65732172 |
143 | Astrocytoma (HP:0009592) | 1.65717778 |
144 | Abnormality of the astrocytes (HP:0100707) | 1.65717778 |
145 | Villous atrophy (HP:0011473) | 1.64388214 |
146 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.64388214 |
147 | Heterotopia (HP:0002282) | 1.63389913 |
148 | Abnormal tarsal ossification (HP:0008369) | 1.62806890 |
149 | Skin tags (HP:0010609) | 1.62791204 |
150 | Obstructive sleep apnea (HP:0002870) | 1.61999893 |
151 | Abnormality of the motor neurons (HP:0002450) | 1.61891885 |
152 | Vertebral compression fractures (HP:0002953) | 1.61705138 |
153 | Insidious onset (HP:0003587) | 1.61678400 |
154 | Termporal pattern (HP:0011008) | 1.61678400 |
155 | Hypoplasia of dental enamel (HP:0006297) | 1.61549647 |
156 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.61468766 |
157 | Aplasia of the phalanges of the hand (HP:0009802) | 1.61468766 |
158 | Aplasia involving bones of the extremities (HP:0009825) | 1.61468766 |
159 | Patellar dislocation (HP:0002999) | 1.61410702 |
160 | Flattened epiphyses (HP:0003071) | 1.61244507 |
161 | Morphological abnormality of the middle ear (HP:0008609) | 1.58449117 |
162 | Abnormality of the thoracic spine (HP:0100711) | 1.58438892 |
163 | Blue sclerae (HP:0000592) | 1.58323218 |
164 | Spina bifida occulta (HP:0003298) | 1.57814609 |
165 | Small epiphyses (HP:0010585) | 1.57761246 |
166 | Deviation of the thumb (HP:0009603) | 1.57277202 |
167 | Polygenic inheritance (HP:0010982) | 1.57041214 |
168 | Neonatal death (HP:0003811) | 1.56260123 |
169 | J-shaped sella turcica (HP:0002680) | 1.55286065 |
170 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.54911575 |
171 | Limited elbow extension (HP:0001377) | 1.53448123 |
172 | Uterine leiomyosarcoma (HP:0002891) | 1.53396774 |
173 | Leiomyosarcoma (HP:0100243) | 1.53396774 |
174 | Precocious puberty (HP:0000826) | 1.53004890 |
175 | Abnormal vertebral ossification (HP:0100569) | 1.52577639 |
176 | Abnormal hand bone ossification (HP:0010660) | 1.52376408 |
177 | Selective tooth agenesis (HP:0001592) | 1.52144167 |
Rank | Gene Set | Z-score |
---|---|---|
1 | CDK12 | 5.80730021 |
2 | ERN1 | 5.58055844 |
3 | GRK6 | 3.61045587 |
4 | MAP3K10 | 3.49649869 |
5 | SMG1 | 3.21493704 |
6 | TGFBR2 | 3.16907317 |
7 | TRIB3 | 2.44509381 |
8 | SIK1 | 2.42934972 |
9 | STK10 | 2.40114403 |
10 | MST1R | 2.34935125 |
11 | PRPF4B | 2.32716870 |
12 | IRAK3 | 2.31970225 |
13 | GRK5 | 2.28896819 |
14 | MAP4K1 | 1.84605734 |
15 | PKN2 | 1.83696481 |
16 | EEF2K | 1.79732386 |
17 | MATK | 1.76768266 |
18 | FGFR4 | 1.59339340 |
19 | * CSF1R | 1.53029270 |
20 | GRK1 | 1.47559526 |
21 | TYRO3 | 1.45493061 |
22 | MET | 1.41854949 |
23 | TYK2 | 1.41780281 |
24 | DDR2 | 1.40965735 |
25 | MAPK7 | 1.38639902 |
26 | SIK2 | 1.35347211 |
27 | ICK | 1.32591562 |
28 | FGFR3 | 1.29774932 |
29 | EPHB2 | 1.27239072 |
30 | PTK6 | 1.26968521 |
31 | CAMK1D | 1.26055172 |
32 | NME2 | 1.23977593 |
33 | CDC42BPA | 1.19835171 |
34 | EPHA2 | 1.18363313 |
35 | BCKDK | 1.16613416 |
36 | LRRK2 | 1.12344378 |
37 | CSK | 1.11888419 |
38 | PAK4 | 1.11759770 |
39 | TTK | 1.08884416 |
40 | MTOR | 1.08704589 |
41 | RPS6KA2 | 1.07893909 |
42 | RIPK1 | 1.06722838 |
43 | LMTK2 | 1.06211209 |
44 | LATS1 | 1.05524253 |
45 | GRK7 | 1.04140515 |
46 | MAP3K7 | 1.02992313 |
47 | ADRBK2 | 0.99724259 |
48 | BLK | 0.96287168 |
49 | PDGFRA | 0.89720625 |
50 | TAOK3 | 0.89523971 |
51 | TAOK1 | 0.88679362 |
52 | TESK1 | 0.87380604 |
53 | CAMK1G | 0.87290089 |
54 | ARAF | 0.87251967 |
55 | JAK1 | 0.86339596 |
56 | WNK1 | 0.85927222 |
57 | PIM2 | 0.85740294 |
58 | MAP2K4 | 0.85265640 |
59 | CDK4 | 0.83307568 |
60 | CAMK4 | 0.80506186 |
61 | NEK2 | 0.78751621 |
62 | MAPK12 | 0.77218790 |
63 | MOS | 0.76668018 |
64 | TTN | 0.74701664 |
65 | RET | 0.74267144 |
66 | MAP2K3 | 0.73528663 |
67 | ALK | 0.73490276 |
68 | SIK3 | 0.72370393 |
69 | PDPK1 | 0.71991212 |
70 | JAK2 | 0.71666783 |
71 | NTRK1 | 0.71518851 |
72 | KSR2 | 0.71453995 |
73 | MARK2 | 0.71317031 |
74 | BRD4 | 0.69538372 |
75 | PRKD2 | 0.69317115 |
76 | CDK6 | 0.67397436 |
77 | PRKG2 | 0.66650460 |
78 | STK3 | 0.65566057 |
79 | FLT3 | 0.64886562 |
80 | RPS6KC1 | 0.64877409 |
81 | RPS6KL1 | 0.64877409 |
82 | MAP2K2 | 0.64105413 |
83 | TAOK2 | 0.62438208 |
84 | CHUK | 0.61200980 |
85 | DYRK1B | 0.60943089 |
86 | TBK1 | 0.60348777 |
87 | PTK2 | 0.59577063 |
88 | MAP3K3 | 0.59000997 |
89 | MAPKAPK3 | 0.58023517 |
90 | FRK | 0.57792414 |
91 | JAK3 | 0.56753945 |
92 | LATS2 | 0.56269940 |
93 | ITK | 0.56134744 |
94 | ERBB2 | 0.52942958 |
95 | AKT3 | 0.52670986 |
96 | PAK2 | 0.51735525 |
97 | CDK7 | 0.51566691 |
98 | HCK | 0.50966883 |
99 | IRAK2 | 0.50476522 |
100 | NEK9 | 0.49922030 |
101 | IKBKB | 0.48575849 |
102 | SCYL2 | 0.48488841 |
103 | BMX | 0.48303447 |
104 | FGR | 0.48017899 |
105 | ZAP70 | 0.47899417 |
106 | AKT2 | 0.47587151 |
107 | MAP3K6 | 0.47575825 |
108 | SYK | 0.47240262 |
109 | SGK3 | 0.47121996 |
110 | HIPK2 | 0.46637954 |
111 | RPS6KB2 | 0.46336854 |
112 | GSK3A | 0.46192152 |
113 | PRKD3 | 0.45434094 |
114 | BCR | 0.45021484 |
115 | PRKAA1 | 0.44284958 |
116 | MAP3K13 | 0.43636851 |
117 | MAP3K1 | 0.43196315 |
118 | MAPK11 | 0.42221768 |
119 | RPS6KA6 | 0.41210040 |
120 | PRKCI | 0.41151739 |
121 | RPS6KA1 | 0.40536251 |
122 | FGFR1 | 0.39382996 |
123 | MAPK4 | 0.38604561 |
124 | MAP3K14 | 0.37823853 |
125 | ROCK2 | 0.37802032 |
126 | CDK9 | 0.37544301 |
127 | PRKCZ | 0.36729391 |
128 | PRKAA2 | 0.36016385 |
129 | RPS6KA4 | 0.35279529 |
130 | CDK11A | 0.35021446 |
131 | KSR1 | 0.34607872 |
132 | MAP3K9 | 0.34418076 |
133 | BTK | 0.33817207 |
134 | CDK15 | 0.33711801 |
135 | PDK1 | 0.33548150 |
136 | KIT | 0.33046406 |
137 | MAP3K8 | 0.32914834 |
138 | PDGFRB | 0.32223925 |
139 | CAMKK1 | 0.32172983 |
140 | MELK | 0.30806538 |
141 | CDK18 | 0.30750559 |
142 | CHEK1 | 0.30403627 |
143 | EPHB1 | 0.30137988 |
144 | ERBB4 | 0.30036934 |
145 | MARK1 | 0.29375170 |
146 | ADRBK1 | 0.28917874 |
147 | CHEK2 | 0.28497782 |
148 | BRAF | 0.28268508 |
149 | MAPK10 | 0.27921741 |
150 | * INSR | 0.27637821 |
151 | * IGF1R | 0.26564284 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.57083618 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.53454151 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.13338979 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.93781301 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.79649496 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.78010903 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.55604089 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38594643 |
9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.07630930 |
10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.07305977 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.00233319 |
12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.00183516 |
13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.99791061 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93684431 |
15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88896484 |
16 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.87976144 |
17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.81315837 |
18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80056253 |
19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.70555780 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.66310627 |
21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60909280 |
22 | Endometrial cancer_Homo sapiens_hsa05213 | 1.54458051 |
23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52105092 |
24 | Bile secretion_Homo sapiens_hsa04976 | 1.46727545 |
25 | Lysine degradation_Homo sapiens_hsa00310 | 1.43162938 |
26 | Thyroid cancer_Homo sapiens_hsa05216 | 1.40872452 |
27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.38425881 |
28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.37107024 |
29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.34803627 |
30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32958640 |
31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.32812962 |
32 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.32758646 |
33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32280407 |
34 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.32079110 |
35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.30851627 |
36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29119103 |
37 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.27438058 |
38 | Peroxisome_Homo sapiens_hsa04146 | 1.27378996 |
39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.26149602 |
40 | ABC transporters_Homo sapiens_hsa02010 | 1.25960765 |
41 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.24845254 |
42 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.20954889 |
43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.20256885 |
44 | Histidine metabolism_Homo sapiens_hsa00340 | 1.19140891 |
45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19103778 |
46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18384667 |
47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.18148678 |
48 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.15283630 |
49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15185351 |
50 | * Focal adhesion_Homo sapiens_hsa04510 | 1.13524945 |
51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.13350955 |
52 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.13165714 |
53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12369042 |
54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.11864802 |
55 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.08304564 |
56 | Axon guidance_Homo sapiens_hsa04360 | 1.07026911 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06999689 |
58 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06064766 |
59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.05641360 |
60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.05184255 |
61 | Amoebiasis_Homo sapiens_hsa05146 | 1.04728724 |
62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.04464151 |
63 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02843232 |
64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.99958507 |
65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.98142143 |
66 | Prostate cancer_Homo sapiens_hsa05215 | 0.97691739 |
67 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94880919 |
68 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.94540022 |
69 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.93708318 |
70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91635765 |
71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.90086299 |
72 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.88109297 |
73 | Tight junction_Homo sapiens_hsa04530 | 0.88077824 |
74 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85800289 |
75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85769224 |
76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84380252 |
77 | Glioma_Homo sapiens_hsa05214 | 0.84322306 |
78 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82499697 |
79 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80582111 |
80 | Insulin resistance_Homo sapiens_hsa04931 | 0.79973223 |
81 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.77428691 |
82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.77130445 |
83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.76557920 |
84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75617169 |
85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.75249870 |
86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.74139163 |
87 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72686876 |
88 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.72245033 |
89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.71687173 |
90 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69185036 |
91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68379721 |
92 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67319226 |
93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67094594 |
94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66739000 |
95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65351433 |
96 | Hepatitis B_Homo sapiens_hsa05161 | 0.61316123 |
97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61283962 |
98 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60750822 |
99 | Influenza A_Homo sapiens_hsa05164 | 0.60129202 |
100 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.58355654 |
101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56714487 |
102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.56583662 |
103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55706063 |
104 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55499591 |
105 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55222326 |
106 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.54189231 |
107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54095628 |
108 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.54016905 |
109 | Salmonella infection_Homo sapiens_hsa05132 | 0.53449303 |
110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.51089551 |
111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.51052049 |
112 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50942999 |
113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50745653 |
114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50426698 |
115 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50357761 |
116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49534108 |
117 | Shigellosis_Homo sapiens_hsa05131 | 0.48168992 |
118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44669015 |
119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.44100448 |
120 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.43653797 |
121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41335818 |
122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40583954 |
123 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37778690 |
124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.37627831 |
125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36926956 |
126 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.35855780 |
127 | Prion diseases_Homo sapiens_hsa05020 | 0.35787690 |
128 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35555493 |
129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35471655 |
130 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35468180 |
131 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34954085 |
132 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33081729 |
133 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.31653435 |
134 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29406673 |
135 | Apoptosis_Homo sapiens_hsa04210 | 0.29314749 |
136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27041531 |
137 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.26684112 |
138 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.26592719 |
139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.26492294 |
140 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.26187399 |
141 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.24904358 |
142 | Adherens junction_Homo sapiens_hsa04520 | 0.23982700 |
143 | Bladder cancer_Homo sapiens_hsa05219 | 0.23805508 |
144 | Leishmaniasis_Homo sapiens_hsa05140 | 0.23269596 |
145 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22683230 |
146 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21133566 |
147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.20963793 |
148 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20836651 |
149 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20595007 |
150 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.18451070 |
151 | Hepatitis C_Homo sapiens_hsa05160 | 0.18415268 |